We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
EBay Stock Dips On In Line Q1 Earnings, Revenue Miss
Read MoreHide Full Article
EBay (EBAY - Free Report) just released its first quarter financial results, posting adjusted earnings of $0.53 per share and revenues of $2.58 billion.
EBay is currently a Zacks Rank #2 (Buy), which is subject to change based on today’s results. Shares of EBay are up 25.5% over the last year and 2.4% in the last four weeks. EBay dipped slightly on Wednesday to hit $40.97 per share prior to the release of its first quarter earnings results.
EBay stock is currently down 4.56% to $39.10 per share in after-hours trading shortly after its earnings report was released.
EBAY:
Matched earnings estimates. The company posted adjusted earnings of $0.53 per share, matching the Zacks Consensus Estimate.
Missed revenue estimates. The company saw revenue figures of $2.58 billion, missing our consensus estimate of $2.6 billion.
EBay’s Q1 revenues jumped roughly 12% from $2.30 billion in the year-ago period. Meanwhile, the online seller’s quarterly earnings climbed 9% from $0.49 per share.
Looking ahead to the second quarter, EBay expects to post adjusted earnings in the range of $0.50 per share to $0.52 per share, which falls in line with our current estimates.
Here’s a graph that looks at EBAY’s Price, Consensus and EPS Surprise history:
Check back later for our full analysis on EBAY’s earnings report!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
EBay Stock Dips On In Line Q1 Earnings, Revenue Miss
EBay (EBAY - Free Report) just released its first quarter financial results, posting adjusted earnings of $0.53 per share and revenues of $2.58 billion.
EBay is currently a Zacks Rank #2 (Buy), which is subject to change based on today’s results. Shares of EBay are up 25.5% over the last year and 2.4% in the last four weeks. EBay dipped slightly on Wednesday to hit $40.97 per share prior to the release of its first quarter earnings results.
EBay stock is currently down 4.56% to $39.10 per share in after-hours trading shortly after its earnings report was released.
EBAY:
Matched earnings estimates. The company posted adjusted earnings of $0.53 per share, matching the Zacks Consensus Estimate.
Missed revenue estimates. The company saw revenue figures of $2.58 billion, missing our consensus estimate of $2.6 billion.
EBay’s Q1 revenues jumped roughly 12% from $2.30 billion in the year-ago period. Meanwhile, the online seller’s quarterly earnings climbed 9% from $0.49 per share.
Looking ahead to the second quarter, EBay expects to post adjusted earnings in the range of $0.50 per share to $0.52 per share, which falls in line with our current estimates.
Here’s a graph that looks at EBAY’s Price, Consensus and EPS Surprise history:
eBay Inc. Price, Consensus and EPS Surprise
eBay Inc. Price, Consensus and EPS Surprise | eBay Inc. Quote
Check back later for our full analysis on EBAY’s earnings report!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>